We are live on ! Find out more
GLSI icon

Greenwich LifeSciences
GLSI

35 hedge funds and large institutions have $19.4M invested in Greenwich LifeSciences in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

0.22% less ownership

Funds ownership: 6.29% → 6.07% (-0.22%)

3% less funds holding

Funds holding: 36 → 35 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

39% less capital invested

Capital invested by funds: $31.9M → $19.4M (-$12.5M)

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.19M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1M
3
Ameriprise
Ameriprise
Minnesota
+$755K
4
BlackRock
BlackRock
New York
+$673K
5
Marshall Wace
Marshall Wace
United Kingdom
+$593K

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$5.79M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$1.13M
3
TEE
Tibra Equities Europe
United Kingdom
-$496K
4
SW
SkyOak Wealth
Michigan
-$289K
5
OMC
Old Mission Capital
Illinois
-$287K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$5.79M +$673K +20,105 +9%
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.65M +$23.2K +693 +0.5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.64M +$351K +10,501 +18%
State Street
4
State Street
Massachusetts
$1.59M +$187K +5,595 +9%
Northern Trust
5
Northern Trust
Illinois
$891K +$4.42K +132 +0.4%
Morgan Stanley
6
Morgan Stanley
New York
$879K +$1.19M +35,461 +5,088%
Millennium Management
7
Millennium Management
New York
$740K +$513K +15,316 +101%
Renaissance Technologies
8
Renaissance Technologies
New York
$730K +$1M +30,000 New
Ameriprise
9
Ameriprise
Minnesota
$701K +$755K +22,569 +358%
Marshall Wace
10
Marshall Wace
United Kingdom
$431K +$593K +17,719 New
HF
11
HRT Financial
New York
$388K +$534K +15,971 New
N
12
Nuveen
North Carolina
$264K – – –
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$254K +$350K +10,450 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$246K +$6.06K +181 +2%
Charles Schwab
15
Charles Schwab
California
$239K – – –
Jane Street
16
Jane Street
New York
$209K +$56.2K +1,679 +24%
SG Americas Securities
17
SG Americas Securities
New York
$107K +$147K +4,395 New
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$86K -$268 -8 -0.2%
Bank of America
19
Bank of America
North Carolina
$76K +$38.5K +1,152 +59%
UBS Group
20
UBS Group
Switzerland
$67K -$51.7K -1,546 -36%
Deutsche Bank
21
Deutsche Bank
Germany
$60K +$4.35K +130 +6%
Wells Fargo
22
Wells Fargo
California
$57K +$74.3K +2,221 +1,777%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$54K -$52K -1,555 -41%
AIG
24
American International Group
New York
$53K -$1.21K -36 -2%
California State Teachers Retirement System (CalSTRS)
25
California State Teachers Retirement System (CalSTRS)
California
$50K -$12.4K -370 -15%
1
2

GLSI Hedge Fund Activity: Q4 2021 in Review

35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2021, worth a combined $19.4M — down 39% from $31.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of GLSI and 6 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 14 added.

The largest buyer was Morgan Stanley, adding an estimated $1.19M. The largest seller was Invesco, exiting entirely with an estimated $5.79M sold.

  • 35 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2021, down from 36 in Q3 2021.
  • Funds reported $19.4M of Greenwich LifeSciences stock for Q4 2021, down 39% quarter-over-quarter.
  • 6 funds opened new Greenwich LifeSciences positions in Q4 2021 and 7 closed out, a net change of -1 holder.
  • The largest Greenwich LifeSciences buyer in Q4 2021 was Morgan Stanley, an estimated $1.19M added.
  • The largest Greenwich LifeSciences seller in Q4 2021 was Invesco, an estimated $5.79M sold.

Based on aggregated 13F filings for Q4 2021.